These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8048831)

  • 1. Neurological crisis in hereditary tyrosinaemia and complete reversal after liver transplantation.
    Noble-Jamieson G; Jamieson N; Clayton P; Bailey S; Ryalls M; Barnes ND
    Arch Dis Child; 1994 Jun; 70(6):544-5. PubMed ID: 8048831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase.
    Gibbs TC; Payan J; Brett EM; Lindstedt S; Holme E; Clayton PT
    J Neurol Neurosurg Psychiatry; 1993 Oct; 56(10):1129-32. PubMed ID: 8410015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic imaging with computed tomography of chronic tyrosinaemia type 1.
    Macvicar D; Dicks-Mireaux C; Leonard JV; Wight DG
    Br J Radiol; 1990 Aug; 63(752):605-8. PubMed ID: 2400875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in tyrosinaemia type I: the Groningen experience.
    Wijburg FA; Reitsma WC; Slooff MJ; van Spronsen FJ; Koetse HA; Reijngoud DJ; Smit GP; Berger R; Bijleveld CM
    J Inherit Metab Dis; 1995; 18(2):115-8. PubMed ID: 7564223
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver transplantation in nine Spanish patients with tyrosinaemia type I.
    Pérez-Cerdá C; Merinero B; Sanz P; Castro M; Gangoiti J; García MJ; Díaz M; Medina E; Ugarte M
    J Inherit Metab Dis; 1995; 18(2):119-22. PubMed ID: 7564224
    [No Abstract]   [Full Text] [Related]  

  • 6. Tyrosinaemia type I: considerations of treatment strategy and experiences with risk assessment, diet and transplantation.
    van Spronsen FJ; Smit GP; Wijburg FA; Thomasse Y; Visser G; Heymans HS
    J Inherit Metab Dis; 1995; 18(2):111-4. PubMed ID: 7564222
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation defect of congenital tyrosinaemia.
    Evans DI; Sardharwalla IB
    Arch Dis Child; 1984 Nov; 59(11):1088-90. PubMed ID: 6508343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in tyrosinaemia type 1: the dilemma of timing the operation.
    Salt A; Barnes ND; Rolles K; Calne RY; Clayton PT; Leonard JV
    Acta Paediatr; 1992 May; 81(5):449-52. PubMed ID: 1323361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.
    Kvittingen EA; Jellum E; Stokke O; Flatmark A; Bergan A; Sødal G; Halvorsen S; Schrumpf E; Gjone E
    J Inherit Metab Dis; 1986; 9(2):216-24. PubMed ID: 3091928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem.
    van Spronsen FJ; Berger R; Smit GP; de Klerk JB; Duran M; Bijleveld CM; van Faassen H; Slooff MJ; Heymans HS
    J Inherit Metab Dis; 1989; 12 Suppl 2():339-42. PubMed ID: 2556611
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal failure in adult patients with hereditary tyrosinaemia type I.
    Kvittingen EA; Talseth T; Halvorsen S; Jakobs C; Hovig T; Flatmark A
    J Inherit Metab Dis; 1991; 14(1):53-62. PubMed ID: 1861460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I hereditary tyrosinaemia: presentation of 11 cases.
    Coşkun T; Ozalp I; Koçak N; Yüce A; Caglar M; Berger R
    J Inherit Metab Dis; 1991; 14(5):765-70. PubMed ID: 1664010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma.
    Van Thiel DH; Gartner LM; Thorp FK; Newman SL; Lindahl JA; Stoner E; New MI; Starzl TE
    J Hepatol; 1986; 3(1):42-8. PubMed ID: 3018074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation in two children with tyrosinaemia type I: biochemical aspects.
    Riudor E; Ribes A; Lloret J; Friden J; Holme E; Jakobs C; Martinez Ibanez V
    J Inherit Metab Dis; 1991; 14(3):281-4. PubMed ID: 1770775
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurologic crises in hereditary tyrosinemia.
    Mitchell G; Larochelle J; Lambert M; Michaud J; Grenier A; Ogier H; Gauthier M; Lacroix J; Vanasse M; Larbrisseau A
    N Engl J Med; 1990 Feb; 322(7):432-7. PubMed ID: 2153931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosinaemia--treatment and outcome.
    Kvittingen EA
    J Inherit Metab Dis; 1995; 18(4):375-9. PubMed ID: 7494396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosinaemia type I and hypertrophic obstructive cardiomyopathy.
    Edwards MA; Green A; Colli A; Rylance G
    Lancet; 1987 Jun; 1(8547):1437-8. PubMed ID: 2884531
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune thyroiditis in a case of tyrosinaemia type III.
    D'Eufemia P; Giardini O; Cantani A; Martino F; Finocchiaro R
    J Inherit Metab Dis; 1992; 15(6):861-2. PubMed ID: 1293381
    [No Abstract]   [Full Text] [Related]  

  • 19. Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II).
    Paige DG; Clayton P; Bowron A; Harper JI
    J R Soc Med; 1992 Dec; 85(12):759-60. PubMed ID: 1362969
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary pneumococcal peritonitis associated with tyrosinaemia type 1.
    Gill DS; Lipscomb AP
    J Inherit Metab Dis; 1999 Apr; 22(2):195-6. PubMed ID: 10234620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.